Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis B virus DNA synthesis is a critical step in the HBV replication cycle, involving the conversion of pregenomic RNA (pgRNA) into viral DNA through a unique reverse transcription process. This mechanism is central to HBV's ability to persist and propagate within host hepatocytes. It is the target of antiviral drugs such as nucleos(t)ide analogs, which inhibit viral replication by interfering with key enzymatic activities required for new viral genome production.
Inhibition of HBV polymerase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis B Virus DNA Synthesis (HBV DNA Synthesis).